Applications in progress
The All-Ireland Cancer Consortium 2026 Scheme opened on 25 Feb 2026 and closed for applications on 27 May 2026 at 13:00. An information webinar took place on 24 March and the recording is available here.
The AICC 2026 call targets funding to support cancer research focused on survivorship, for people living well with and beyond a cancer diagnosis. Cancer survivorship research covers the period from diagnosis to treatment outcome and seeks to improve care and outcomes experienced by people living with and past cancer. It will enable support of cross-border cooperation and joint efforts in cancer survivorship research to ultimately benefit people, living across the island of Ireland and beyond.
Applications are currently undergoing peer/public reviews and outcomes will be issued in mid-August with the right to reply opened for applicants proceeding to Panel review.
Secondary Data Analysis Projects (SDAP 2025)
The Secondary Data Analysis Projects (SDAP) are designed to bring together researchers, knowledge users and data controllers to develop research projects that answer policy and/or practice-relevant questions by using secondary data.
Cycle 2 opened for applications on 1 September 2025 and closed on 9 January 2026 at 13:00. The scheme has been extremely competitive and all applicants have been informed of the outcome regarding their proposals. Six applications were approved for funding by the HRB Board following the panel’s recommendations.
Investigator-led Clinical Trials (ILCT) Programme 2025 (formerly DIFA)
The Cycle 3 submission deadline was in December 2025. 57 applications were received. Eligibility checks are completed, with eligible applications moving to peer and public review. Following peer and public review applicants will be shortlisted and invited to submit a right of reply to peer/public review comments. The shortlisted applications will be considered by the international panel acknowledging public/peer review comments and applicants’ right of reply in October 2026. Results will be available in early December 2026 following HRB Board approval.
Investigator-Led Projects (ILP) 2026
The ILP scheme aims to support highly innovative and internationally competitive investigator-led projects that can respond to existing and emerging challenges for health and social care. The ILP provides funding for clearly defined research projects in: (i) Patient-oriented research (POR), (ii) Population health research (PHR), and (iii) Health services research (HSR). 29 (18 POR, 6 PHR and 5 HSR), applications were approved by the HRB board in June. Outcome letters have been issued and budget negotiations for successful awards commenced.
Research in-Practice Fellowships for Health and Social Care Practitioners (RPF) 2026
The applicant response stage is now completed for the 16 candidates shortlisted and invited for interview, and the panel review phase commenced in early July. The interviews with an international panel are scheduled for 2 and 3 of September.
HRCI-HRB Joint Funding Scheme 2026
The HRCI-HRB Joint Funding Scheme aims to fund researchers and research teams to conduct internationally competitive and innovative research in areas of strategic relevance to each individual HRCI-registered co-funding charity. 12 applications were approved by the HRB board in June. Outcome letters have been issued and budget negotiations for successful awards commenced.
Collaborative Postdoctoral Fellowships Programme (CPFP) 2026
Peer and public review are currently on the way for the ten leadership teams invited to full application stage. The Interview panel is scheduled for 10 – 11 November 2026.
The “Test and Demonstration of Multimodal Data Approaches for Personalised Medicine (MultiPMData2026)’ RITC call has two stages for applicants, both of which have now closed. Full proposals are currently under review and overall outcome results expected in early September.
European Rare Diseases Research Alliance (ERDERA) Joint Transnational Call (JTC) 2026
‘Resolving unsolved cases in rare genetic and non-genetic diseases’ is the ERDERA JTC 2026 call topic. Ffull proposals were due by 8 July 2026 and are currently undergoing review. Outcomes will be released towards the end of the year.
European Partnership on Transforming Health and Care Systems (THCS) 2026
The full proposal was 30 June 2026. Full proposals are now under review and decisions are expected in October to November 2026.
European Partnership on One Health Antimicrobial Resistance (OHAMR) 2026
The deadline for submitting full proposals has passed, and full proposals are currently under review. The overall outcome results are expected by the end of October.
Conference and Event Sponsorship Scheme 2026
This scheme aims to create an opportunity to host health research related events, workshops, or conferences on the island of Ireland. Up to a maximum of €5,000 per grant is available. 70 applications were received to Cycle 2, 66 eligible applications will move to selection by randomisation in mid-August. .
The Applied Partnership Awards – Women’s Health (APA-WH) 2026
The Applied Partnership Awards Women’s Health (APA-WH) 2026 deadline for applications was 1 April 2026. The public and peer review stages are now complete.Shortlisted proposals are currently under panel review with the panel review meeting scheduled to take place 09 and 10 September. Results are expected to be available in October 2026 following HRB Board approval.
Open Calls
US-Ireland Research and Development Partnership Programme
This is a rolling call. The call guidance has been updated and can be found here. Check the scheme notice for full details – US-Ireland R&D Partnership Programme.
Other European research funding opportunities
See our EU funding updates story for information on more European research funding opportunities.
See also general information on the Horizon Europe and EU4Health programmes.
